{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:18:45Z","timestamp":1791299925542,"version":"4.1.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170258","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T18:56:49Z","timestamp":1484852209000},"page":"e0170258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4025-190X","authenticated-orcid":true,"given":"Emilie","family":"Baro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Galperine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanette","family":"Denies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Lannoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Lenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Guery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Dervaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/CMR.00127-14","article-title":"Diversity and Evolution in the Genome of Clostridium difficile","volume":"28","author":"DR Knight","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"21059","DOI":"10.2807\/1560-7917.ES2015.20.10.21059","article-title":"Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012","volume":"20","author":"DW Eyre","year":"2015","journal-title":"Euro Surveill"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12879-016-1610-3","article-title":"Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach","volume":"16","author":"K Desai","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"Suppl 6","key":"ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1469-0691.12046","article-title":"Can we identify patients at high risk of recurrent Clostridium difficile infection?","volume":"18","author":"CP Kelly","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhin.2016.04.004","article-title":"Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study","volume":"93","author":"DN Shah","year":"2016","journal-title":"J Hosp Infect"},{"issue":"Suppl 2","key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"SB Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"E van Nood","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"G Cammarota","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"ref9","first-page":"7","article-title":"Economic studies part I: basics and terms","volume":"3","author":"NB Henrikson","year":"2012","journal-title":"Evid-Based Spine-Care J"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/cid\/ciu128","article-title":"Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis","volume":"58","author":"GG Konijeti","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/cit346","article-title":"Is fidaxomicin worth the cost? An economic analysis","volume":"57","author":"SM Bartsch","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jval.2012.11.004","article-title":"Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States","volume":"16","author":"PM Stranges","year":"2013","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/1469-0691.12805","article-title":"Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection","volume":"20","author":"RU Varier","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1017\/ice.2014.80","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"36","author":"RU Varier","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"e0149521","DOI":"10.1371\/journal.pone.0149521","article-title":"Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection","volume":"11","author":"L Lapointe-Shaw","year":"2016","journal-title":"PloS One"},{"key":"ref16","unstructured":"Hood GM. PopTools version 3.2.5. 2010. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.poptools.org\" xlink:type=\"simple\">http:\/\/www.poptools.org<\/ext-link>"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/jac\/dku257","article-title":"Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection","volume":"69","author":"D Nathwani","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"A676","DOI":"10.1016\/j.jval.2014.08.2512","article-title":"Cost-Effectiveness of Fecal Microbiota Transplant in Treating Clostridium Difficile Infection in Canada","volume":"17","author":"H Zowall","year":"2014","journal-title":"Value Health"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhin.2009.10.016","article-title":"Economic healthcare costs of Clostridium difficile infection: a systematic review","volume":"74","author":"SS Ghantoji","year":"2010","journal-title":"J Hosp Infect"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1155\/2014\/793532","article-title":"Clinical and economic consequences of vancomycin and fidaxomicin for the treatment of Clostridium difficile infection in Canada","volume":"25","author":"M Wagner","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/cid\/cis495","article-title":"Fidaxomicin failures in recurrent Clostridium difficile infection: a problem of timing","volume":"55","author":"R Orenstein","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cis833","article-title":"Fidaxomicin \u201cchaser\u201d regimen following vancomycin for patients with multiple Clostridium difficile recurrences","volume":"56","author":"S Johnson","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"ofu069","DOI":"10.1093\/ofid\/ofu069","article-title":"Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies","volume":"1","author":"MM Soriano","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/IPC.0000000000000181","article-title":"Fidaxomicin Use and Clinical Outcomes for Clostridium difficile-Associated Diarrhea","volume":"23","author":"EH Eiland","year":"2015","journal-title":"Infect Dis Clin Pract Baltim Md"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/phar.1451","article-title":"An antimicrobial stewardship program\u2019s real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series","volume":"34","author":"CA Vargo","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/hcp118","article-title":"Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series","volume":"102","author":"AA MacConnachie","year":"2009","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.7326\/0003-4819-149-9-200811040-00245","article-title":"Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force","volume":"149","author":"EP Whitlock","year":"2008","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00464-007-9251-7","article-title":"Colonoscopic perforations: a review of 30,366 patients","volume":"21","author":"TH L\u00fcning","year":"2007","journal-title":"Surg Endosc"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1463-1318.2011.02899.x","article-title":"Colonoscopy-associated perforation: a 7-year survey of in-hospital frequency, treatment and outcome in a German university hospital","volume":"14","author":"AF Hagel","year":"2012","journal-title":"Colorectal Dis"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-137-2-200207160-00007","article-title":"Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force","volume":"137","author":"M Pignone","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1052-5157(18)30364-7","article-title":"Complications of upper gastrointestinal endoscopy","volume":"6","author":"MF Chan","year":"1996","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-013-0337-1","article-title":"Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions","volume":"15","author":"TJ Borody","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10096-014-2088-9","article-title":"The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema","volume":"33","author":"CH Lee","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"OA Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"TJ Louie","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/bjs.8868","article-title":"Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis","volume":"99","author":"A Bhangu","year":"2012","journal-title":"Br J Surg"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/codi.12134","article-title":"Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review","volume":"15","author":"DB Stewart","year":"2013","journal-title":"Colorectal Dis"},{"key":"ref38","article-title":"Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation","author":"H Sokol","year":"2015","journal-title":"Dig Liver Dis"},{"key":"ref39","unstructured":"European Antimicrobial Resistance Surveillance Network (EARS-Net). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/EARS-Net\/Pages\/index.aspx\" xlink:type=\"simple\">http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/EARS-Net\/Pages\/index.aspx<\/ext-link>"},{"key":"ref40","unstructured":"Caisse nationale de l\u2019Assurance maladie. Nomenclature des actes de biologie m\u00e9dicale. 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.codage.ext.cnamts.fr\/codif\/nabm\/index_presentation.php?p_site=AMELI\" xlink:type=\"simple\">http:\/\/www.codage.ext.cnamts.fr\/codif\/nabm\/index_presentation.php?p_site=AMELI<\/ext-link>"},{"key":"ref41","unstructured":"Direction g\u00e9n\u00e9rale de l\u2019offre de soins. Calcul des co\u00fbts par activit\u00e9, donn\u00e9es 2013. 2013; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/social-sante.gouv.fr\/IMG\/pdf\/Rapport_Base_d_Angers_-_Donnees_2013.pdf\" xlink:type=\"simple\">http:\/\/social-sante.gouv.fr\/IMG\/pdf\/Rapport_Base_d_Angers_-_Donnees_2013.pdf<\/ext-link>"},{"key":"ref42","unstructured":"Insee\u2014Tableaux de l\u2019\u00c9conomie Fran\u00e7aise - \u00c9dition 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.insee.fr\/fr\/publications-et-services\/sommaire.asp?ref_id=TEF14\" xlink:type=\"simple\">http:\/\/www.insee.fr\/fr\/publications-et-services\/sommaire.asp?ref_id=TEF14<\/ext-link>"},{"key":"ref43","unstructured":"Direction g\u00e9n\u00e9rale de l\u2019offre de soins. Guide pour le suivi de la masse salariale. Minist\u00e8re charg\u00e9 de la sant\u00e9; 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/social-sante.gouv.fr\/IMG\/pdf\/Guide_suivi_masse_salariale_23-03-15.pdf\" xlink:type=\"simple\">http:\/\/social-sante.gouv.fr\/IMG\/pdf\/Guide_suivi_masse_salariale_23-03-15.pdf<\/ext-link>"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOG.0b013e32835a4b3e","article-title":"Fecal microbiota transplantation: past, present and future","volume":"29","author":"OC Aroniadis","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"key":"ref45","unstructured":"Inspection G\u00e9n\u00e9rale des Affaires Sociales. Evaluation de la tarification des soins hospitaliers et des actes m\u00e9dicaux. 2012 Apr. Report No.: 2011-NaN-056\u201301."},{"key":"ref46","unstructured":"R\u00e9f\u00e9rentiel de co\u00fbts MCO 2013 | Stats ATIH. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.scansante.fr\/r%C3%A9f%C3%A9rentiel-de-co%C3%BBts-mco-2013\" xlink:type=\"simple\">http:\/\/www.scansante.fr\/r%C3%A9f%C3%A9rentiel-de-co%C3%BBts-mco-2013<\/ext-link>"},{"key":"ref47","article-title":"Department of Public Health","author":"M Stouthard","year":"1997"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial","volume":"149","author":"P Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"ref49","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"LV McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/IPC.0b013e31829ff59b","article-title":"Patients With Recalcitrant Clostridium difficile\u2013Associated Diarrhea Treated Successfully With Fidaxomicin: A Case Series","volume":"22","author":"BR Bono","year":"2014","journal-title":"Infect Dis Clin Pract"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/AAC.04268-14","article-title":"Fidaxomicin therapy in critically ill patients with Clostridium difficile infection","volume":"59","author":"S Penziner","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1155\/2014\/695029","article-title":"Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection","volume":"28","author":"MA Khan","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"ref53","first-page":"475","article-title":"Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy","volume":"46","author":"G Cammarota","year":"2014","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"ref54","first-page":"1","article-title":"Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation","volume":"7","author":"R Pathak","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"MJ Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2011.11.037","article-title":"Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection","volume":"142","author":"E Mattila","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MCG.0b013e3181dadb10","article-title":"Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology","volume":"44","author":"F Rohlke","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"ref58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCG.0b013e3181dac035","article-title":"Treatment of refractory\/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients","volume":"44","author":"SS Yoon","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.anaerobe.2012.11.004","article-title":"Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series","volume":"19","author":"TA Rubin","year":"2013","journal-title":"Anaerobe"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"J Aas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection","volume":"172","author":"Z Kassam","year":"2012","journal-title":"Arch Intern Med"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cgh.2010.01.007","article-title":"Success of self-administered home fecal transplantation for chronic Clostridium difficile infection","volume":"8","author":"MS Silverman","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8648","key":"ref63","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0140-6736(89)92749-9","article-title":"Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients","volume":"1","author":"M Tvede","year":"1989","journal-title":"Lancet Lond Engl"},{"issue":"8","key":"ref64","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10096-011-1522-5","article-title":"Hospital-acquired Clostridium difficile infection: determinants for severe disease","volume":"31","author":"JM Wenisch","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2168.1998.00519.x","article-title":"Timing of surgery for fulminating pseudomembranous colitis","volume":"85","author":"K Synnott","year":"1998","journal-title":"Br J Surg"},{"issue":"4","key":"ref66","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/000313481007600421","article-title":"Colectomy for fulminant Clostridium difficile colitis: predictors of mortality","volume":"76","author":"AD Perera","year":"2010","journal-title":"Am Surg"},{"issue":"2","key":"ref67","first-page":"150","article-title":"Predictors of mortality after colectomy for fulminant Clostridium difficile colitis","volume":"143","author":"JC Byrn","year":"2008","journal-title":"Arch Surg Chic Ill 1960"},{"issue":"4","key":"ref68","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.gie.2011.07.025","article-title":"Complications of colonoscopy","volume":"74","author":"DA Fisher","year":"2011","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2307\/30145589","article-title":"Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982\u20131991","volume":"15","author":"MM Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1086\/502023","article-title":"Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals","volume":"23","author":"MA Miller","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2010.03.025","article-title":"A review of mortality due to Clostridium difficile infection","volume":"61","author":"JA Karas","year":"2010","journal-title":"J Infect"},{"issue":"9","key":"ref72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1445-2197.2007.04226.x","article-title":"Is laparoscopic colectomy for cancer cost-effective relative to open colectomy?","volume":"77","author":"JL Hayes","year":"2007","journal-title":"ANZ J Surg"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11605-010-1155-5","article-title":"Avoiding or reversing Hartmann\u2019s procedure provides improved quality of life after perforated diverticulitis","volume":"14","author":"J Vermeulen","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"ref74","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study","volume":"58","author":"I Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref75","article-title":"Endoscopic peroral jejunal fecal microbiota transplantation","author":"A Link","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Z Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref77","article-title":"Report of the Commission on Macroeconomics and Health","year":"2001"},{"key":"ref78","unstructured":"Insee\u2014Tableau\u20141.115\u2014Produit int\u00e9rieur brut et revenu national brut par habitant (Milliers de personnes, Milliards d\u2019euros et Euros par personne). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.insee.fr\/fr\/themes\/comptes-nationaux\/tableau.asp?sous_theme=1&xml=t_1115\" xlink:type=\"simple\">http:\/\/www.insee.fr\/fr\/themes\/comptes-nationaux\/tableau.asp?sous_theme=1&amp;xml=t_1115<\/ext-link>"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jval.2013.02.010","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"16","author":"D Husereau","year":"2013","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ijcp.12320","article-title":"Faecal microbiota transplantation for Clostridium difficile infection","volume":"68","author":"M Dodin","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"4","key":"ref81","first-page":"230","article-title":"Intestinal Microbiota and the Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Disease","volume":"10","author":"OC Aroniadis","year":"2014","journal-title":"Gastroenterol Hepatol"},{"issue":"Pt 11","key":"ref82","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1099\/mic.0.042010-0","article-title":"A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin","volume":"156","author":"GW Tannock","year":"2010","journal-title":"Microbiol Read Engl"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jiac.2015.01.011","article-title":"Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients","volume":"21","author":"S Di Bella","year":"2015","journal-title":"J Infect Chemother"},{"issue":"7","key":"ref84","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","author":"CR Kelly","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"ref85","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial","volume":"315","author":"CH Lee","year":"2016","journal-title":"JAMA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T05:04:16Z","timestamp":1601355856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170258"}},"subtitle":[],"editor":[{"given":"John","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}